World Immunization Week, April 20-27

Read more

Rift Valley Fever Virus Vaccination Development

707
Rift Valley
Rift Valley Fever Virus Vaccination Development
United States of America
To assist in the development of novel vaccines and comprehensive strategies for the prevention of Rift Valley Fever virus in both livestock and humans using recombinant proteins and 96-well ELISA or Luminex platforms to detect anti-NP, anti-NSs or anti-NSm antibodies.
Texas A&M University
CDC’s National Center for Emerging and Zoonotic Infectious Diseases

Improving Pneumococcal Vaccine

659
vaccine
Improving Pneumococcal Vaccine
United States of America
To compare the immunogenicity of current vaccines for pneumococcal disease (native pneumococcal polysaccharide vaccine) with a proposed new vaccination method (microsphere entrapped pneumococcal capsular polysaccharides delivered either subcutaneously or intranasally).
Georgia Research Alliance
CDC's National Center for Immunization and Respiratory Diseases; Emory University; Mercer University
Subscribe to Vaccines